A recent study from the Netherlands has tested the effectiveness of Nightwatch, a new seizure detection device. This device is a bracelet which uses factors like heart rate and movement to recognise “major seizures”.
Support Epilepsy Ireland by getting involved in ‘Purple Day 2019’ and host a purple themed event such as a Coffee Morning, Wear Purple to Work/School, Purple Run or create your own event. You could also ask your local town hall to light up purple to raise awareness about epilepsy. To find out more, contact our Purple Day Coordinator Luke Meany on 01 4557500 or email@example.com.
Epilepsy Ireland has recently been informed by Contactors Medical Bureau, the company who provide the emergency contact service linked to the Epi Alert Bracelet, that they are closing the service from Friday 21st December.
We regret that this long-standing service is to close. Unfortunately, the circumstances are outside of our control. After this date, users of the service are advised not to wear the Epi Alert bracelets any longer.
GW Pharmaceuticals has announced positive top-line results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial of EPIDIOLEX® (cannabidiol or CBD) CV in the treatment of seizures associated with Dravet Syndrome.
The winners of our Mega-raffle draw has been made by Epilepsy Ireland CEO, Peter Murphy which was overseen by solicitor, Stephen Bradley.
1st Prize €2000, Ticket No:14181. G. Daly
2nd Prize €1000, Ticket No: 00713. K. Kennedy
3rd Prize €500, Ticket No: 24433 M.Healy
Sellers prize €200 H. Pescod
From today, the Health Products Regulatory Authority (HPRA) is taking part in the third annual social media campaign to promote the importance of reporting suspected side effects from medicines.
The HSE sodium valproate (Epilim) Patient Support Helpline will close this Friday (November 16th).
The Patient Support Team can help if you took Epilim during a previous pregnancy and may be concerned about your child or the drug.
[Update: Contact details removed as the Helpline has now been closed]
A new research grant has been awarded to Royal College of Surgeons in Ireland under the 2017/2018 round of the Epilepsy Ireland Research Funding Scheme. This project will again open up new possibilities and most importantly has potential to deliver tangible benefits for patients with autoimmune epilepsy.